vs
Amphastar Pharmaceuticals, Inc.（AMPH）与Traeger, Inc.（COOK）财务数据对比。点击上方公司名可切换其他公司
Amphastar Pharmaceuticals, Inc.的季度营收约是Traeger, Inc.的1.3倍（$183.1M vs $145.4M），Amphastar Pharmaceuticals, Inc.净利率更高（13.3% vs -11.8%，领先25.2%），Amphastar Pharmaceuticals, Inc.同比增速更快（-1.8% vs -13.8%），Amphastar Pharmaceuticals, Inc.自由现金流更多（$24.6M vs $14.2M），过去两年Amphastar Pharmaceuticals, Inc.的营收复合增速更高（3.2% vs 0.2%）
安福斯制药是一家上市的美国特种制药企业，公司成立于2004年5月，核心业务为吸入制剂及鼻腔给药产品的研发、生产与销售，聚焦特色医药领域深耕发展。
Traeger, Inc.是一家专注于户外烹饪设备研发生产的企业，主营高端木颗粒烤炉、配套配件及专用木颗粒燃料，主要面向北美、欧洲、澳洲市场，通过零售渠道和直营模式服务家庭及商用餐饮客户。
AMPH vs COOK — 直观对比
营收规模更大
AMPH
是对方的1.3倍
$145.4M
营收增速更快
AMPH
高出12.0%
-13.8%
净利率更高
AMPH
高出25.2%
-11.8%
自由现金流更多
AMPH
多$10.4M
$14.2M
两年增速更快
AMPH
近两年复合增速
0.2%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $183.1M | $145.4M |
| 净利润 | $24.4M | $-17.2M |
| 毛利率 | 46.8% | 37.4% |
| 营业利润率 | 19.4% | -8.0% |
| 净利率 | 13.3% | -11.8% |
| 营收同比 | -1.8% | -13.8% |
| 净利润同比 | -35.7% | -147.2% |
| 每股收益（稀释后） | $0.51 | $-0.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMPHCOOK
| Q4 25 | $183.1M | $145.4M | ||
| Q3 25 | $191.8M | $125.4M | ||
| Q2 25 | $174.4M | $145.5M | ||
| Q1 25 | $170.5M | $143.3M | ||
| Q4 24 | $186.5M | $168.6M | ||
| Q3 24 | $191.2M | $122.0M | ||
| Q2 24 | $182.4M | $168.5M | ||
| Q1 24 | $171.8M | $144.9M |
净利润AMPHCOOK
| Q4 25 | $24.4M | $-17.2M | ||
| Q3 25 | $17.4M | $-89.8M | ||
| Q2 25 | $31.0M | $-7.4M | ||
| Q1 25 | $25.3M | $-778.0K | ||
| Q4 24 | $38.0M | $-7.0M | ||
| Q3 24 | $40.4M | $-19.8M | ||
| Q2 24 | $37.9M | $-2.6M | ||
| Q1 24 | $43.2M | $-4.7M |
毛利率AMPHCOOK
| Q4 25 | 46.8% | 37.4% | ||
| Q3 25 | 51.4% | 38.7% | ||
| Q2 25 | 49.6% | 39.2% | ||
| Q1 25 | 50.0% | 41.5% | ||
| Q4 24 | 46.5% | 40.9% | ||
| Q3 24 | 53.3% | 42.3% | ||
| Q2 24 | 52.2% | 42.9% | ||
| Q1 24 | 52.4% | 43.2% |
营业利润率AMPHCOOK
| Q4 25 | 19.4% | -8.0% | ||
| Q3 25 | 13.2% | -66.5% | ||
| Q2 25 | 24.2% | -4.2% | ||
| Q1 25 | 21.9% | 2.4% | ||
| Q4 24 | 24.2% | -0.1% | ||
| Q3 24 | 29.8% | -6.1% | ||
| Q2 24 | 30.3% | 2.8% | ||
| Q1 24 | 27.9% | -0.1% |
净利率AMPHCOOK
| Q4 25 | 13.3% | -11.8% | ||
| Q3 25 | 9.0% | -71.6% | ||
| Q2 25 | 17.8% | -5.1% | ||
| Q1 25 | 14.8% | -0.5% | ||
| Q4 24 | 20.4% | -4.1% | ||
| Q3 24 | 21.1% | -16.2% | ||
| Q2 24 | 20.8% | -1.5% | ||
| Q1 24 | 25.1% | -3.2% |
每股收益（稀释后）AMPHCOOK
| Q4 25 | $0.51 | $-0.13 | ||
| Q3 25 | $0.37 | $-0.67 | ||
| Q2 25 | $0.64 | $-0.06 | ||
| Q1 25 | $0.51 | $-0.01 | ||
| Q4 24 | $0.74 | $-0.06 | ||
| Q3 24 | $0.78 | $-0.15 | ||
| Q2 24 | $0.73 | $-0.02 | ||
| Q1 24 | $0.81 | $-0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $282.8M | $19.6M |
| 总债务越低越好 | $608.7M | $403.3M |
| 股东权益账面价值 | $788.8M | $170.8M |
| 总资产 | $1.6B | $676.0M |
| 负债/权益比越低杠杆越低 | 0.77× | 2.36× |
8季度趋势，按日历期对齐
现金及短期投资AMPHCOOK
| Q4 25 | $282.8M | $19.6M | ||
| Q3 25 | $276.2M | $5.9M | ||
| Q2 25 | $231.8M | $10.3M | ||
| Q1 25 | $236.9M | $12.0M | ||
| Q4 24 | $221.6M | $15.0M | ||
| Q3 24 | $250.5M | $16.9M | ||
| Q2 24 | $217.8M | $18.0M | ||
| Q1 24 | $289.6M | $23.6M |
总债务AMPHCOOK
| Q4 25 | $608.7M | $403.3M | ||
| Q3 25 | $608.6M | — | ||
| Q2 25 | $607.7M | — | ||
| Q1 25 | $603.9M | — | ||
| Q4 24 | $601.6M | $403.6M | ||
| Q3 24 | $596.4M | — | ||
| Q2 24 | $586.9M | — | ||
| Q1 24 | $594.0M | — |
股东权益AMPHCOOK
| Q4 25 | $788.8M | $170.8M | ||
| Q3 25 | $776.7M | $186.1M | ||
| Q2 25 | $757.5M | $274.2M | ||
| Q1 25 | $751.3M | $279.6M | ||
| Q4 24 | $732.3M | $276.4M | ||
| Q3 24 | $727.7M | $279.8M | ||
| Q2 24 | $713.3M | $297.3M | ||
| Q1 24 | $672.4M | $294.6M |
总资产AMPHCOOK
| Q4 25 | $1.6B | $676.0M | ||
| Q3 25 | $1.7B | $689.6M | ||
| Q2 25 | $1.6B | $780.6M | ||
| Q1 25 | $1.6B | $825.6M | ||
| Q4 24 | $1.6B | $830.7M | ||
| Q3 24 | $1.5B | $818.1M | ||
| Q2 24 | $1.5B | $842.4M | ||
| Q1 24 | $1.6B | $862.1M |
负债/权益比AMPHCOOK
| Q4 25 | 0.77× | 2.36× | ||
| Q3 25 | 0.78× | — | ||
| Q2 25 | 0.80× | — | ||
| Q1 25 | 0.80× | — | ||
| Q4 24 | 0.82× | 1.46× | ||
| Q3 24 | 0.82× | — | ||
| Q2 24 | 0.82× | — | ||
| Q1 24 | 0.88× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $32.9M | $15.5M |
| 自由现金流经营现金流 - 资本支出 | $24.6M | $14.2M |
| 自由现金流率自由现金流/营收 | 13.4% | 9.8% |
| 资本支出强度资本支出/营收 | 4.5% | 0.9% |
| 现金转化率经营现金流/净利润 | 1.35× | — |
| 过去12个月自由现金流最近4个季度 | $121.2M | $13.6M |
8季度趋势，按日历期对齐
经营现金流AMPHCOOK
| Q4 25 | $32.9M | $15.5M | ||
| Q3 25 | $52.6M | $7.6M | ||
| Q2 25 | $35.6M | $18.3M | ||
| Q1 25 | $35.1M | $-20.8M | ||
| Q4 24 | $29.0M | $7.5M | ||
| Q3 24 | $60.0M | $15.1M | ||
| Q2 24 | $69.1M | $13.9M | ||
| Q1 24 | $55.3M | $-12.6M |
自由现金流AMPHCOOK
| Q4 25 | $24.6M | $14.2M | ||
| Q3 25 | $47.2M | $6.4M | ||
| Q2 25 | $25.0M | $15.7M | ||
| Q1 25 | $24.4M | $-22.7M | ||
| Q4 24 | $16.6M | $5.5M | ||
| Q3 24 | $46.2M | $12.8M | ||
| Q2 24 | $63.1M | $11.8M | ||
| Q1 24 | $46.5M | $-18.3M |
自由现金流率AMPHCOOK
| Q4 25 | 13.4% | 9.8% | ||
| Q3 25 | 24.6% | 5.1% | ||
| Q2 25 | 14.3% | 10.8% | ||
| Q1 25 | 14.3% | -15.8% | ||
| Q4 24 | 8.9% | 3.3% | ||
| Q3 24 | 24.1% | 10.5% | ||
| Q2 24 | 34.6% | 7.0% | ||
| Q1 24 | 27.1% | -12.6% |
资本支出强度AMPHCOOK
| Q4 25 | 4.5% | 0.9% | ||
| Q3 25 | 2.8% | 0.9% | ||
| Q2 25 | 6.1% | 1.8% | ||
| Q1 25 | 6.3% | 1.3% | ||
| Q4 24 | 6.7% | 1.2% | ||
| Q3 24 | 7.2% | 1.9% | ||
| Q2 24 | 3.3% | 1.2% | ||
| Q1 24 | 5.1% | 3.9% |
现金转化率AMPHCOOK
| Q4 25 | 1.35× | — | ||
| Q3 25 | 3.03× | — | ||
| Q2 25 | 1.15× | — | ||
| Q1 25 | 1.39× | — | ||
| Q4 24 | 0.76× | — | ||
| Q3 24 | 1.48× | — | ||
| Q2 24 | 1.82× | — | ||
| Q1 24 | 1.28× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMPH
| Other Products | $62.4M | 34% |
| Baqsimi | $46.7M | 26% |
| Primatenemist | $27.9M | 15% |
| Epinephrine | $17.1M | 9% |
| Lidocaine | $14.9M | 8% |
| Glucagon | $14.1M | 8% |
COOK
| Grills | $60.6M | 42% |
| Accessories | $49.2M | 34% |
| Consumables | $35.5M | 24% |
